Julie A. Gelms, RN, BSN, PA-C EDUCATION
Degrees: Physician Assistant/Associates of Liberal Arts and Science
Graduate Studies/ Research in Clinical Psychology and Bereavement
Degree: BSN, Bachelors of Science in Nursing
. PROFESSIONAL EXPERIENCE 2006-Present The Center for Hematology-Oncology/Boca Raton Community Hospital, Inc. 6282 Linton Blvd. Delray Beach, FL,33484 / 701 NW 13th Street, Boca Raton, FL33486, /7593 Boynton Beach Blvd. Boynton Beach, FL 33437/800 Meadows Road Boca Raton, FL 33486
Physician Assistant-Hematology/Oncology Clinical Responsibilities: Outpatient clinical management of Hematology- Oncology Patients
2005-2006 Private
Consultant to local start up company developing home based surveillance
and monitoring system for homebound chronically ill elderly Patients 2000- 2005 University of Chicago Hospital, Chicago, IL
Senior Physician Assistant: Bone Marrow Transplant Team
Clinical Responsibilities:
Inpatient and Outpatient clinical management of Stem Cell
Academic Responsibilities:
Preceptor to Clinical Oncology rotation students at University of Chicago
Author/Monitor of written guidelines for the University of Chicago
2005 Procedures:
Team Member:
Patient Education Committee on Stem Cell Transplant Unit
Christ Hospital and Medical Center, Oak Lawn, IL
Medical Oncology RN Clinical Responsibilities:
Provided inpatient and outpatient primary care Chemotherapy Administration/Venous access maintenance Team Member:
Interdisciplinary team member Narcotic Task Force Committee
Facilitate support group sessions and provide patient and family teaching
RESEARCH/PUBLCATIONS:
Artz, N. Dieterle, J.Gelms, S. Parsad, R. Larson, W. Stock, C.
Daugherty, T. Zimmerman, O. Odenike, S. Smith, K.Van Besien. Valacyclovir compared to Acyclovir for cytomegalovirus prophylaxis in allogeneic stem cell transplant recipients. (Poster, presented at IBMTR, 2003)
Hacker, E. D., Ferrans, C. E., Verlen, E., Ravandi, F., Van Besien, K., Gelms, J., & Dieterle, N. (in press). Fatigue and Physical Activity in Patients Receiving Hematopoeitic Stem Cell Transplantation. Oncology Nursing Forum. (Published May 2006)
Koen Van Besien, Sonali Smith, Olatoyoyosi Odenike, Chris Daugherty, Todd Zimmerman, Michael Thirman, Demetria Collins-Jones, Diane Switzer, Nathalie Dieterle, Julie Gelms, Dorie Sher, Richard Larson, Amittha Wickrema, Wendy Stock section of Hematology/Oncology, University of Chicago, Chicago IL, USA2611 Alemtuzumab (Campath) Based GVHD Prophylaxis Leads to Improved Survival after Allogeneic Transplantation for Patients with Advanced Hematologic Malignancies. Session Type: Poster Session 782-II RESEARCH/PUBLICATIONS:
Specialized international examiner training of patients involved in a Phase II Randomized single blinded study of Extracorporeal Photoimmune (ECP) therapy in conjunction with standard therapy compared to standard therapy alone in patients with steroid refractory Graft versus Host Disease of the skin.
Phi Theta Kappa Honor Society Member 1997-1999
LICENSURE:
APTT ELLAGIC ACID Valuation of activated Partial Thromboplastin Time (APTT) in plasma use manual and automatic procedure TEST SUMMARY The contact system is activated by the ellagic acid. • As with any diagnostic procedure, if the results are The cephalic extracted from bovine brain take effect as inconsistent with the clinical presentation, the substitute for PF3. The clot form
Grandes manoeuvres dans la pharmacie américaine LE MONDE | 10.03.09 | 10h18 • Mis à jour le 10.03.09 | 11h58Six semaines après le rachat du laboratoire américain Wyeth par son compatriote Pfizer pour 68 mil iards de dol ars, une autre opération géante vient rebattre les cartes du secteur pharmaceutique. Merck a annoncé, lundi 9 mars, l'acquisition de Schering-Plough pour 41,1 mil iard